ExcellGene SA
Brooke Williams is an experienced business development professional currently serving as Business Development Manager at ExcellGene SA since January 2024. Prior to this role, Brooke held similar positions at Forecyte Bio Limited from January 2023 to January 2024 and Cytiva from May 2021 to January 2023, where responsibilities included sales support. Earlier career experience includes roles as a Research Technician at the Gene Therapy Program at the University of Pennsylvania and the Children's Hospital of Philadelphia Research Institute, as well as conducting a research project at Loyola University New Orleans focusing on the epidemiological impact of kissing bugs. Brooke holds a Bachelor of Applied Science in Environmental Science from Loyola University New Orleans, earned in 2017.
This person is not in any offices
ExcellGene SA
Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.